WILMINGTON, DE / ACCESSWIRE / July 5, 2023 / The global market stood at US$ 2.8 billion in 2021 and the global ultra-large volume wearable injectors market is projected to reach US$ 6.6 billion in 2031. The global ultra-large volume wearable injectors industry is anticipated to expand at a CAGR of 9.1% between 2022 and 2031.
The global market has been divided into retail pharmacies and drug stores, e-commerce, and others. High market share held by the retail pharmacies and drug stores segment is due to an increased number of patients that are preferring ultra-large volume wearable injectors for various drug deliveries.
Insightful Research at Your Convenience: Get a Sample PDF Copy Now
"Connect with our team of research specialists and unlock the optimal solution for driving your business growth"
Retail pharmacies and drug stores sell different wearable injectors and hence, this has become convenient for purchasing and usage. Owing to the hectic lifestyle CVDs are the number one cause of death, globally, taking an estimated 17.9 million lives each year.
Key Takeaways of Market Report
- Global market to generate absolute dollar opportunity worth US$ 6.6 billion until 2031
- Global ultra-large volume wearable injectors market from 2023 to 2031 is 9.1%
- Global ultra-large volume wearable injectors market is currently valued at US$ 3.02 billion in 2022
- Global ultra-large volume wearable injectors market stood at US$ 2.8 billion in 2021
- Market value of the global ultra-large volume wearable injectors market management from 2018 to 2022 is 8.54%
- North America is said to have a market share of 42%
- Europe market region is estimated to have a market share of 24%
Get Customization on this Report for Specific Research Solutions at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=78474
Ultra-large Volume Wearable Injectors Market: Growth Drivers
- Self-administration devices are being increasingly used, as most of the people prefer treating themselves at the convenience of their home or own space. After the onset of the COVID-19 pandemic, most of the people preferred home treatment, as they did not want to contract the infection. COVID-19 prompted the use of self-administration devices among people who required continuous drug delivery or treatment. Wearable injectors market is estimated to grow due to the dependency of individuals on self-administration devices.
- Chronic diseases, such as diabetes, cardiovascular disorders, autoimmune disorders, and various types of cancer, are the leading causes of death and disability worldwide. According to the Centers for Disease Control and Prevention (CDC) in 2019, nearly six in 10 individuals suffer from, at least, one chronic disease in the U.S.
- Cardiovascular diseases (CVDs) are a significant cause of mortality, globally, owing to the hectic lifestyle. As per the World Health Organization (WHO), CVDs are the number one cause of death, globally, taking an estimated 17.9 million lives each year. According to the International Diabetes Federation (IDF), around 537 million adults (aged 20 -79) are living with diabetes globally where it has been stated that the number of diabetic patients would increase to 643 million by 2030 and 783 million by the year 2045.
- In diabetes patients, exogenous insulin is usually administered through a subcutaneous route of administration for diabetes management. The wearable injector is an ideal drug delivery method for painless and accurate dosages of insulin.
Ultra-large Volume Wearable Injectors Market: Regional Landscape
- North America dominated the global ultra large volume wearable injectors market. The growth of the market in the region can be attributed to an increase in prevalence of chronic diseases, such as cancer, diabetes, oncology, cardiovascular diseases; development of new products, and presence of key market players in the region. Furthermore, technological advancements in the treatment of diseases are expected to be a key driver for the ultra-large volume wearable injectors market in the U.S. and Canada.
- Asia Pacific is the expected to be fastest growing market for ultra-large volume wearable injectors, owing to increase in geriatric population, rise in prevalence of chronic diseases, supportive government initiatives, and research in the field of wearable medical devices. Additionally, investments by international market players fuel the growth of the market.
Ultra-large Volume Wearable Injectors Market: Key Players
- Sensile Medical, Sanofi, and Verily joined forces for the development and commercialization of the connected insulin patch pump. This partnership between three parties is focused on the development and commercialization of a new generation of "all-in-one" pre-filled insulin patch pump. It is primarily used in patients with type 2 diabetes.
- Becton, Dickinson, and Company completed the 50-subject human clinical trial with the BD Libertas Wearable Injector
Buy this Premium Research Report | Immediate Delivery Available at https://www.transparencymarketresearch.com/checkout.php?rep_id=78474<ype=S
Ultra-large Volume Wearable Injectors Market: Segmentation
- By Indication
- Diabetes
- Autoimmune Diseases
- Oncology
- Others
- By Distribution Channel
- Retail Pharmacies & Drug stores
- E-commerce
- Others
- By Region
- North America
- Latin America
- Europe
- Latin America
- Middle East and Africa
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]
SOURCE: Transparency Market Research Inc.